Thus if such modifications account for the difference in response between At Risk and COPD cells, then alteration of RelB levels (via siRNA) in At Risk fibroblasts would be ineffectual in altering smoke-induced Cox-2 expression. The gene discussed is RELB; the disease is chronic obstructive pulmonary disease.